A large proportion of drinking water is abstracted for treatment from lowland rivers--about 30% in the UK--and this water is at particular risk from sudden and poisonous industrial or agricultural pollution. To cover the range of potential pollutants it may be possible to use biosensors as broadband monitors for toxins. The underlying assumption is that some biological processes, when challenged with a toxin, will be affected in a way analogous to that of man, and that therefore on-line scrutiny of such processes will provide early warning of substances liable to be detrimental to human health. Suitable processes for study might involve multi-cellular organisms, whole cells or enzymes. To date, most practical work has concentrated on fish, but enzymes and single cells hold out the promise of quicker response and, possibly, easier maintenance.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0265-928x(86)80008-6DOI Listing

Publication Analysis

Top Keywords

biosensors help
4
help protect
4
protect drinking
4
drinking water?
4
water? large
4
large proportion
4
proportion drinking
4
drinking water
4
water abstracted
4
abstracted treatment
4

Similar Publications

Digital phenotyping from wearables using AI characterizes psychiatric disorders and identifies genetic associations.

Cell

December 2024

Program in Computational Biology and Biomedical Informatics, Yale University, New Haven, CT 06511, USA; Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06511, USA; Department of Computer Science, Yale University, New Haven, CT 06511, USA; Department of Biomedical Informatics and Data Science, Yale University, New Haven, CT 06511, USA; Department of Statistics and Data Science, Yale University, New Haven, CT 06511, USA. Electronic address:

Psychiatric disorders are influenced by genetic and environmental factors. However, their study is hindered by limitations on precisely characterizing human behavior. New technologies such as wearable sensors show promise in surmounting these limitations in that they measure heterogeneous behavior in a quantitative and unbiased fashion.

View Article and Find Full Text PDF

Continuous Biosensing to Monitor Acute Systemic Inflammation, a Diagnostic Need for Therapeutic Guidance.

ACS Sens

December 2024

Department of Laboratory Medicine, Laboratory of Medical Immunology, Radboud Community for Infectious Diseases, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands.

Continuous monitoring of acute inflammation can become a very important next step for guiding therapeutic interventions in severely ill patients. This Perspective discusses the current medical need for patients with acute inflammatory diseases and the potential of continuous biosensing technologies. First, we discuss biomarkers that could help to monitor the state of a patient with acute systemic inflammation based on theoretical studies and empirical data.

View Article and Find Full Text PDF

Technologies and Sensors for Artificial Muscles in Rehabilitation.

Sensors (Basel)

November 2024

Department of Surgery, University of Alberta, Edmonton, AB T6G 2B7, Canada.

Muscles are very important parts of the human body. When there is an injury to a muscle that causes long-term dysfunctionality, sensors and artificial muscles can be used to help alleviate problems. Muscles have complex structures; thus, ultrasound and other types of scans may be needed to determine their parameters and model their shapes.

View Article and Find Full Text PDF

This review summarizes the latest progress in enzyme preparation, including enzyme design and modification technology, exploration of new enzyme sources, and application of enzyme preparation in food processing, detection, and preservation. The directed evolution technology improved the stability and catalytic efficiency of enzymes, while enzyme immobilization technology enhanced reusability and industrial applicability. Extremozymes and biomimetic enzymes exhibit excellent performance under harsh conditions.

View Article and Find Full Text PDF

Introduction: Coronary artery disease (CAD) and peripheral artery disease (PAD) increase the risks of cardiovascular events and death. Digital health technologies are rapidly expanding to improve healthcare quality and access. The Care4Today Connect (C4T CAD-PAD) mobile application is designed to help patients with CAD and/or PAD improve medication adherence, learn about their disease, make lifestyle modifications, and enhance healthcare provider (HCP) connection via an HCP-facing portal.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!